Enzymatic Resolution of Racemic Esters for High Optical Purity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing optically active α-hydroxy compounds have limitations in achieving high optical purity and efficiency, with existing techniques yielding compounds with only 2.4-9.7% enantiomeric excess (ee), which is not sufficient for many applications.
Innovation Solution
A combination of chemical and biochemical methods involving the reaction of an ester compound with a racemic compound in the presence of an enzyme, such as lipase, to produce optically active α-hydroxy derivatives with enhanced optical purity, potentially exceeding 95% ee, as demonstrated by the use of lipase Amano PS from Pseudomonas Cepacia, allowing for the separation and transformation of enantiomers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If chemical reduction methods using arylglyoxylic acid are used to produce optically active α-hydroxyesters, then the production process is simple, but the enantiomeric excess is low (2.4-9.7% ee)
Solution Approach 1:
The patent uses an ester compound as an intermediary reagent that reacts with the racemic α-hydroxy compound in the presence of lipase. This intermediary enables the enzyme to selectively transform one enantiomer while leaving the other unchanged, thereby achieving high enantiomeric excess through the intermediary's mediating role in the resolution process
Solution Approach 2:
The patent changes the reaction parameters by introducing lipase enzyme and ester compound under controlled conditions (temperature, solvent system). These parameter changes transform the simple chemical reduction process into a biocatalytic resolution process that achieves >95% ee while maintaining operational simplicity
2Reliability
If asymmetric reduction of α-ketoesters using microorganisms or baker's yeast is used, then optically active compounds can be produced, but the enantiomeric excess remains limited (2.4-9.7% ee)
Solution Approach 1:
The ester compound serves as a mediator that facilitates selective enzyme-substrate interaction. The lipase enzyme specifically recognizes and transforms one enantiomer of the racemic mixture in the presence of the ester intermediary, achieving high stereoselectivity and enantiomeric excess that cannot be obtained through direct microbial reduction alone
Solution Approach 2:
The patent employs a composite approach combining chemical reagents (ester compound, lipase enzyme) with the racemic substrate. This composite system creates a synergistic effect where the enzyme's biocatalytic activity and the ester's chemical properties work together to achieve high enantiomeric excess, surpassing the limitations of single-method approaches
3Manufacturing precision
If conventional resolution methods are used, then racemic compounds can be separated, but the process generates significant waste and requires complex purification procedures
Solution Approach 1:
The patent converts the harmful waste generation problem into a benefit by using lipase-catalyzed dynamic kinetic resolution. The enzyme selectively transforms one enantiomer into a different product while the other enantiomer remains unchanged, allowing complete consumption of the racemic starting material with minimal waste and simplified purification
Solution Approach 2:
The lipase enzyme performs self-service by automatically achieving enantiomer separation through its inherent stereoselectivity. The enzyme naturally recognizes and transforms one enantiomer preferentially, eliminating the need for complex external purification procedures and reducing waste generation through efficient atom economy
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the production of optically active α-hydroxy derivatives with high optical purity, reducing waste and simplifying purification processes, and allows for the complete consumption of one enantiomer, thereby improving the efficiency and optical purity of the resulting compounds.
Implementation Method 1
reacting an ester compound with a racemic compound in the presence of an enzyme to obtain optically active α-hydroxy derivatives
Data Source
AI summary
The invention relates to compounds, compositions, methods of using and processes for producing optically active a-hydroxy derivatives using a combination of a chemical and biochemical methods. The process comprises reacting an ester compound with a racemic compound in the presence of an enzyme to obtain compounds (compositions and methods). The compounds produced may be useful for starting materials for physiologically active materials, functional materials and the like.